Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to HIV and harm reduction services

New report by UNAIDS highlights the urgent need to implement a human rights and evidence- informed approach to reach people who inject drugs with essential health services

Continue reading “Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to HIV and harm reduction services”

People who use drugs of Estonia and Kazakhstan at the 65 session of the CESCR

Geneva, 65 session of the UN Committee on Economic, Social and Cultural Rights

February 18 – March 8, 2019

In February, 2019 during the 65 session of the UN Committee on Economic, Social and Cultural Rights (CESCR*) in Geneva EHRA in partnership with Canadian HIV/AIDS Legal Network, joined by community representatives from Estonia and Kazakhstan and legal experts from the Human Rights Clinic from Miami University School of Law presented the statements on the enjoyment of rights among women who use drugs in Estonia and access to opioid substitution treatment for people who use drugs in Kazakhstan, and addressed the questions of the Committee.

Continue reading “People who use drugs of Estonia and Kazakhstan at the 65 session of the CESCR”

ToR for consultant to develop the Framework, Methodology and Instrument(s)

EHRA is looking for the consultant to develop the Framework, Methodology and Instrument(s) to assess the impact of the transition from Global Fund’s support to national funding on the programmatic sustainability of OST services.

Consultancy task
In order to assess the impact of transition on the sustainability of the programmatic aspects of OST services in the selected countries the OST Programmatic Sustainability Assessment Framework (OPSAF) should be developed which will identify the specific thematic areas of sustainability to be analyzed as well as indicators specific for each area identified to be measured. Specific methodology for such assessment as well as the relevant instrument\tool allowing to do such measurements should be developed as well.
Specifically, the programmatic sustainability of OST services could be analyzed by understanding the impact of transition related processes on such aspects of the quality of OST service provision (but not exclusively limiting by them only) as:

• Coverage of estimated opioid user population
• Waiting time to first treatment admission
• Methadone/buprenorphine dosage
• Availability of OST (including new initiations) in prisons
• Coverage of OST medicine by state /health insurance
• Toleration of illicit drug consumption (after dose induction phase)
• Diagnosis or detailed assessment of current substance use, individualized treatment
planning
• Availability of take-home OST
• Counselling required

Other programmatic aspects to be assessed could be composition of the OST services being provided, standards being applied, monitoring system in place, involvement of NGOs and community representatives in services provision etc. Additionally, the proposed Framework should allow to consider the influence of the local political and financial aspect of the OST service provision on its programmatic sustainability within the transition.

How to apply
The candidates are invited to submit their CV and Letter of Interest by e-mail referenced under title “Consultant to develop OPSAF” to ivan@harmreductioneurasia.org by 24:00 EET, 04 of March 2019. Letter of Interest and CV should clearly reflect the competencies of the candidate required to complete this task.

Please read the Terms of Reference for more information

ToR OST Sustainability Assesment Framework

Developing the capacity of CCM members representing civil society in Central Asia: a two-day workshop took place in Almaty, Kazakstan

On February 13-14, 2019 in Almaty, Kazakhstan, the Eurasian Harm Reduction Association (EHRA), within the framework of the Regional Communication and Coordination Platform project in the EECA region, with the support of the Global Fund, held a two-day workshop on “Developing the capacity of CCM members representatives civil society in Central Asia” for CCM representatives from the non-governmental sector from 4 countries of Central Asia – Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan.

Continue reading “Developing the capacity of CCM members representing civil society in Central Asia: a two-day workshop took place in Almaty, Kazakstan”

EHRA and the Alliance for Public Health call to join the Valentine’s Day Global Action in support of the Global Fund’s efforts to ensure the necessary level of investment within the Sixth Replenishment

On the 11th January 2019, the Global Fund announced its fundraising target for the next three-year cycle for 2020 – 2022. The Executive Summary of the Sixth Replenishment Investment Case describes how a minimum of US$14 billion will help save 16 million lives, cut the mortality rate from HIV, TB and malaria in half, and build stronger health systems by 2023. The Global Fund’s Sixth Replenishment Conference will take place in Lyon (France) on 10 October 2019.

Continue reading “EHRA and the Alliance for Public Health call to join the Valentine’s Day Global Action in support of the Global Fund’s efforts to ensure the necessary level of investment within the Sixth Replenishment”

Robert Carr Network Fund announcing the Funding Decision for the period 2019-2021

We are happy to announce that RCNF acknowledged the achievements of the Eurasian Regional Consortium in the HIV response in the EECA region and provided USD 1,760,000 to continue the Consortium advocacy and capacity building activities in respond to funding insecurity for HIV services for key populations in EECA for the next three years.

Continue reading “Robert Carr Network Fund announcing the Funding Decision for the period 2019-2021”

Lithuania rings a bell – “Reform of the Psychoactive Substances: Support, don’t Punish” Conference has started in Vilnius

The aim of the Conference is to show the overall drug policy situation in the international context and how it affects people, who use drugs; to provide to the audience the historical context that led Czech Republic and Norway to the decision of decriminalizing drug use and possession for use; to teach and share with Lithuanian legislators best practices of the drug policy reforms, by giving more international expertise.

Continue reading “Lithuania rings a bell – “Reform of the Psychoactive Substances: Support, don’t Punish” Conference has started in Vilnius”

Time to Act! The 4th European Harm Reduction Conference

November 21, 2018

11.45 – 12.30

Panel discussion: Harm Reduction future: sustainability and impact

Moderator: Ganna Dovbakh and Wolfgang Phillipp

Naomi Burke-Shyne, HRI

Katya Lukicheva, OSI

Palani Narayanan, Global Fund

Susanna Ronconi, Forum Droghe, Italy

Marian Ursan, Carusel, Romania

12.30 – 12.45

“Chase the Virus, not People!”

Ganna Dovbakh, EHRA

16.00 – 17.30

Parallel session 7*: Bringing treatment to the community (HA REACT) 

Chair: Alexandra Gurinova

Co-organised by the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT), HA-REACT addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis and viral hepatitis, among people who inject drugs (PWID). It is a joint effort of 23 organisations in 18 EU Member States, and focuses on those countries where there are obvious gaps in effective and evidence-informed harm reduction interventions, or where such interventions are not being implemented at a sufficient level.

Gender approach in testing and other harm reduction interventions

• Alexandra Gurinova, Deutsche Aids Hilfe, Germany

• Olga Belyayeva, Eurasian Harem Reduction Association, Lithuania

Integrated care for people who use drugs – challenges and recommendations

• Kristel Kivimets, National Institute for Health Development, Estonia

Responding to HIV and overdose epidemics in Estonia

• Aljona Kurbatova, National Institute for Health Development, Estonia

Drug policy change through the lens of OST treatment implementation in Lithuania

• Morgana Daniele, Youth Rise, UK

November 22, 2018

11.00 – 12.30

Parallel session 12*: Transition and sustainable funding of harm reduction (OSF), part 1

Room: 2 – MIRCEA ELIADE
Chair: Ekaterina Lukicheva

This session aims to increase the understanding of progress and key success factors that lead to sustainability of HR programs in countries transitioning from Global Fund’s support of HIV response to national funding including the role civil society and community representatives plays in these processes.

Participants will:

  • Learn about the harm reduction financing changes and donor transition related processes taking place in SEE countries
  • Better understand key facilitators and factors that lead to their programmatic and financial sustainability
  • Learn from the experience of civil society and community representatives advocating for sustainability of HIV prevention services among key affected populations in their countries.

14.00 – 15.30

Parallel session 17*: How to leverage EU membership and accession for increasing sustainability and quality of harm reduction services at country level (OSI part 2).

Room 2 – MIRCEA ELIADE
Chair: Raminta Stuikyte

This sesison will discuss the challenges, lessons learnt and possible opportunities for NGOs in those EU member counties which lack of the political will to ensure the sustainability of harm reduction services at the expense of the state budget
Participants will:

  • Learn more about the political, technical, funding opportunities and instruments available for NGO in EU member and accession countries which could help to improve the sustainability of HR services they provide
  • Get an opportunity to discuss their situations, share their concerns and learn from each other’s experiences of advocating for the increase of the governmental funding for HR services

November 23, 2018

09.00 – 10.30

Parallel Session 26: Drug policy trends: alternative to coercive sanctions

Room: 1 – Aula
Chair: Ganna Dovbakh

This session aims to provide space for discussion on current drug policy trends in Europe, the impact of international drug policies on European national policies and practice and the ways of transferring European best practices to other regions.

Participants will:

  • Increase their understanding of the perspective of young people on the international and national drug policies;
  • Learn about the current state of advocacy for decriminalization, legalization and alternatives to coercive sanctions (ACS) in Europe;
  • Learn about pilot diversion from arrest programs in EU and barriers to their integration;
  • Share perspectives of EU best practices in drug policy that could be promoted outside of the EU.

Shrinking space for harm reduction and human rights in EU based on Hungarian situation

Peter Sarosi, Drugreporter, Hungary

Promotion of Alternatives to Coercive Sanctions (ACS) Programs in EECA

Dasha Matyushina, Eurasian Harm Reduction Association, Russia

Guidelines for law enforcement to improve public health outcomes for YPUD

Morgana Daniele, Youth Rise, UK

09.00 – 10.30

Parallel session 29 : Gendered consequences of repressive drug policies

Room: 4 – Simion Mehedinti
Chair: Eliza Kurcevič

The session aims to provide space for women who use drugs and specialists working with this group to share and discuss gender specific consequences of repressive drug policies and the availability and quality of existing services inclusion of the community in the global women’s movement.

Participants will:

  • Learn about recent studies of human rights violations of women who use drugs and the process of submitting complaints to UN bodies
  • Increase their knowledge of intersectional feminism and the inclusion of the community of women who use drugs in the global feminist movement
  • Learn about gender differences in substance use and the prevalence of HIV and HCV, and gender-sensitive services including services for women who use drugs who suffered from violence
  • Discuss how to protect and minimize risks among activists and human rights defenders

Gender differences among people who inject drugs (PWID) in Estonia

Maris Salekesin, National Institute for Health Development, Estonia

Human Rights of Women Who Use Drugs: Institutional Violence and Human Rights Abuse by OST Clinics’ Staff

Maria Plotko, Eurasian Harm Reduction Association, Lithuania

Harm Reduction Challenge: public nuisance vs public health

Aura Ruig, Metzineres, Spain

Protection of Harm Reduction and Community Activists from Pressure, Arbitrary Arrest and other Forms of Abuse by Authorities

Dasha Matyushina, Eurasian Harm Reduction Association, Russia

Harm reduction from perspective of feminism and history of the feminist movement

Fenya Fischler, Association for Women’s Rights in Development, UK

 

* – The list of the sessions, in which the representatives of EHRA’s team took part in their preparation